181 related articles for article (PubMed ID: 7068217)
1. Activation of monocyte and granulocyte antibody-dependent cytotoxicity by phorbol myristate acetate.
Klassen DK; Conkling PR; Sagone AL
Infect Immun; 1982 Mar; 35(3):818-25. PubMed ID: 7068217
[TBL] [Abstract][Full Text] [Related]
2. Evidence for both oxygen and non-oxygen dependent mechanisms of antibody sensitized target cell lysis by human monocytes.
Klassen DK; Sagone AL
Blood; 1980 Dec; 56(6):985-92. PubMed ID: 7437519
[TBL] [Abstract][Full Text] [Related]
3. Uncoupling of oxidative and non-oxidative mechanisms in human granulocyte-mediated cytotoxicity: use of cytoplasts and cells from chronic granulomatous disease patient.
van Kessel KP; van Strijp JA; van Kats-Renaud HJ; Miltenburg LA; Fluit AC; Verhoef J
J Leukoc Biol; 1990 Oct; 48(4):359-66. PubMed ID: 2168467
[TBL] [Abstract][Full Text] [Related]
4. Effect of catalase on the proliferation of human lymphocytes to phorbol myristate acetate.
Sagone AL; Husney R; Guter H; Clark L
J Immunol; 1984 Sep; 133(3):1488-94. PubMed ID: 6747295
[TBL] [Abstract][Full Text] [Related]
5. Phorbol myristate acetate-induced modulation of antibody-dependent cellular cytotoxicity by human polymorphonuclear leukocytes.
Ichinose Y; Yagawa K; Kaku M; Hara N; Ohta M
Infect Immun; 1984 Dec; 46(3):682-5. PubMed ID: 6094356
[TBL] [Abstract][Full Text] [Related]
6. Role of oxygen intermediates in cytotoxicity: studies in chronic granulomatous disease.
Roberts RL; Ank BJ; Fanger MW; Shen L; Stiehm ER
Inflammation; 1993 Feb; 17(1):77-92. PubMed ID: 8432564
[TBL] [Abstract][Full Text] [Related]
7. Ox erythrocyte cytotoxicity by phorbol myristate acetate-activated human neutrophils.
Dallegri F; Patrone F; Bonvini E; Gahrton G; Holm G; Sacchetti C
Scand J Immunol; 1983 Feb; 17(2):109-14. PubMed ID: 6300993
[TBL] [Abstract][Full Text] [Related]
8. Phorbol myristate acetate induced neutrophil autotoxicity.
Tsan MF
J Cell Physiol; 1980 Nov; 105(2):327-34. PubMed ID: 7193215
[TBL] [Abstract][Full Text] [Related]
9. Chemotactic peptide enhancement of PMA triggered monocyte cytotoxicity.
Dallegri F; Patrone F; Ballestrero A; Frumento G; Sacchetti C
Clin Exp Immunol; 1984 Sep; 57(3):717-21. PubMed ID: 6467686
[TBL] [Abstract][Full Text] [Related]
10. Role of oxygen in antibody-dependent cytotoxicity mediated by monocytes and neutrophils.
Borregaard N; Kragballe K
J Clin Invest; 1980 Oct; 66(4):676-83. PubMed ID: 6252248
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-mediated nonoxidative tumor lysis stimulated by high concentrations of phorbol myristate acetate.
Lichtenstein A
Clin Immunol Immunopathol; 1988 Jun; 47(3):296-309. PubMed ID: 2836117
[TBL] [Abstract][Full Text] [Related]
12. On the mechanism of enhanced monocyte and neutrophil cytotoxicity in severe psoriasis.
Herlin T; Borregaard N; Kragballe K
J Invest Dermatol; 1982 Aug; 79(2):104-8. PubMed ID: 6284840
[TBL] [Abstract][Full Text] [Related]
13. Human polymorphonuclear leukocyte-mediated cytotoxicity against varicella-zoster virus-infected fibroblasts.
Ihara T; Starr SE; Ito M; Douglas SD; Arbeter AM
J Virol; 1984 Jul; 51(1):110-6. PubMed ID: 6328030
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil erythrotoxicity induced by phorbol myristate acetate: mechanisms involved in neutrophil activation.
Geffner JR; Fontán PA; Sordelli DO; Isturiz MA
J Leukoc Biol; 1991 Apr; 49(4):352-9. PubMed ID: 2002283
[TBL] [Abstract][Full Text] [Related]
15. Phorbol myristate acetate-induced neutrophil autotoxicity. A comparison with H2O2 toxicity.
Tsan MF; Denison RC
Inflammation; 1980 Dec; 4(4):371-80. PubMed ID: 7461822
[TBL] [Abstract][Full Text] [Related]
16. Regulation of neutrophil inflammatory mediator release: chemotactic peptide activation of stimulus-dependent cytotoxicity.
English D; Lukens JN
J Immunol; 1983 Feb; 130(2):850-6. PubMed ID: 6294178
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal capacity of phorbol myristate acetate-treated human polymorphonuclear leukocytes.
Wang-Iverson P; Pryzwansky KB; Spitznagel JK; Cooney MH
Infect Immun; 1978 Dec; 22(3):945-55. PubMed ID: 730386
[TBL] [Abstract][Full Text] [Related]
18. Oxidative mechanisms of monocyte-mediated cytotoxicity.
Weiss SJ; LoBuglio AF; Kessler HB
Proc Natl Acad Sci U S A; 1980 Jan; 77(1):584-7. PubMed ID: 6244567
[TBL] [Abstract][Full Text] [Related]
19. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.
Colotta F; Bersani L; Lazzarin A; Poli G; Mantovani A
J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a nonoxidative mechanism of human natural killer (NK) cell cytotoxicity by using mononuclear effector cells from healthy donors and from patients with chronic granulomatous disease.
Kay HD; Smith DL; Sullivan G; Mandell GL; Donowitz GR
J Immunol; 1983 Oct; 131(4):1784-8. PubMed ID: 6311897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
